UCB
UCB opens Belgian pilot plant
September 17, 2012Manufacturing and Production Amgen, Belgium, R&D, UCB
UCB has officially opened a new pilot biotech plant at its Braine-L’Alleud site in Belgium.The 5,100 sq. m. facility – …
UCB signs new epilepsy research pact with Imperial
May 21, 2012Research and Development, Sales and Marketing R&D, Scotland, UCB, epilepsy
UCB has signed a two-year research deal with Imperial College London to find disease-modifying targets in epilepsy. The firm has …
UCB launches ‘Parkinson’s Well-Being Map’
April 13, 2012Medical Communications Parkinson's disease, UCB
UCB has launched a new visual tool to help people with Parkinson’s Disease to discuss their health and symptoms with …
EMG appoints two new senior members
April 4, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing EMG, Matthew Speers, Steve Turley, UCB
A new chair and vice-chair have been appointed to lead the European Medicines Group (EMG). EMG is the voice of …
UCB nominates new board members
March 26, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB, board members
UCB has nominated Harriet Edelman and Charles-Antoine Janssen to become new members of UCB’s board of directors. The new nominations …
UCB signs £3.6m research deal with Oxford University
March 20, 2012Research and Development, Sales and Marketing Oxford University, UCB, collaboration, research
UCB Pharma and Oxford University have signed an R&D collaboration agreement covering immunology and neurology. The idea is to pool …
UCB chief executive to chair IMI
March 12, 2012Business Services, Manufacturing and Production, Research and Development, Sales and Marketing IMI, Roch, UCB
UCB has confirmed that its chief executive Roch Doliveux has been appointed chairman of the governing board of the Innovative …
UCB releases ‘Epilepsy In Our Time’ video diaries
February 17, 2012Medical Communications UCB, epilepsy
UCB has released Epilepsy In Our Time, a video diary that explores life with epilepsy from the perspective of those …
Cimzia results excite UCB in psoriatic arthritis
February 16, 2012Research and Development, Sales and Marketing Cimzia, UCB, psoriatic arthritis
UCB will submit Cimzia for psoriatic arthritis by the end of 2012, after positive Phase III trial results for the …
Otsuka and UCB scale down collaboration
January 16, 2012Research and Development, Sales and Marketing Lundbeck, Otsuka, UCB
Otsuka and UCB have scaled back the scope of their collaboration, and will now focus on developing drugs for the …
UCB appoints Peter Theil as head of non-clinical development
November 28, 2011Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB
Peter Theil has joined UCB as its new vice president and head of non-clinical development for the firm’s new medicines …
UCB will double staff at Swiss bioproduction facility
November 15, 2011Manufacturing and Production UCB, manufacturing
Belgian pharmaceutical company UCB showcased its new bioproduction facility in Bulle, Switzerland, yesterday, saying that the workforce there looks set …
UCB and Amgen’s osteoporosis drug shows promise
April 21, 2011Research and Development Amgen, UCB, osteoporosis
Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …
UCB teams up with Harvard for CNS research
March 2, 2011Research and Development CNS, Harvard, UCB, academia, academic research, immunology
UCB has signed a new research collaboration with Harvard University that will focus on central nervous system and immunology therapies. …
UCB plans €250m plant to meet Cimzia demand
December 29, 2010Manufacturing and Production Cimzia, Switzerland, UCB, pharma manufacturing
Belgian biotechnology company UCB has started construction of a new microbial manufacturing facility in Bulle, Switzerland to help meet demand …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
